Amedisys, Inc. (AMED)
USD 84.97
(-0.47%)
USD 84.97
(-0.47%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.23 Billion USD | 0.59% |
| 2022 | 2.22 Billion USD | 0.41% |
| 2021 | 2.21 Billion USD | 6.88% |
| 2020 | 2.07 Billion USD | 5.93% |
| 2019 | 1.95 Billion USD | 17.63% |
| 2018 | 1.66 Billion USD | 8.4% |
| 2017 | 1.53 Billion USD | 6.69% |
| 2016 | 1.43 Billion USD | 12.25% |
| 2015 | 1.28 Billion USD | 6.31% |
| 2014 | 1.2 Billion USD | -3.59% |
| 2013 | 1.24 Billion USD | -16.03% |
| 2012 | 1.48 Billion USD | 1.19% |
| 2011 | 1.47 Billion USD | -10.03% |
| 2010 | 1.63 Billion USD | 7.99% |
| 2009 | 1.51 Billion USD | 27.46% |
| 2008 | 1.18 Billion USD | 70.13% |
| 2007 | 697.93 Million USD | 28.97% |
| 2006 | 541.14 Million USD | 41.83% |
| 2005 | 381.55 Million USD | 68.02% |
| 2004 | 227.08 Million USD | 59.39% |
| 2003 | 142.47 Million USD | 10.08% |
| 2002 | 129.42 Million USD | 17.47% |
| 2001 | 110.17 Million USD | 21.4% |
| 2000 | 90.75 Million USD | -6.83% |
| 1999 | 97.41 Million USD | 155.77% |
| 1998 | 38.08 Million USD | -30.11% |
| 1997 | 54.49 Million USD | 18.31% |
| 1996 | 46.06 Million USD | 22.5% |
| 1995 | 37.6 Million USD | 53.47% |
| 1994 | 24.5 Million USD | 75.0% |
| 1993 | 14 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 571.41 Million USD | 0.11% |
| 2024 Q2 | 591.18 Million USD | 3.46% |
| 2023 FY | 2.23 Billion USD | 0.59% |
| 2023 Q4 | 570.78 Million USD | 2.62% |
| 2023 Q1 | 556.38 Million USD | -1.01% |
| 2023 Q2 | 552.96 Million USD | -0.61% |
| 2023 Q3 | 556.23 Million USD | 0.59% |
| 2022 Q4 | 562.06 Million USD | 0.73% |
| 2022 Q2 | 557.89 Million USD | 2.32% |
| 2022 Q1 | 545.25 Million USD | -2.51% |
| 2022 Q3 | 557.98 Million USD | 0.02% |
| 2022 FY | 2.22 Billion USD | 0.41% |
| 2021 Q4 | 559.31 Million USD | 1.05% |
| 2021 FY | 2.21 Billion USD | 6.88% |
| 2021 Q1 | 537.14 Million USD | -2.46% |
| 2021 Q2 | 564.16 Million USD | 5.03% |
| 2021 Q3 | 553.48 Million USD | -1.89% |
| 2020 Q3 | 544.07 Million USD | 12.17% |
| 2020 Q4 | 550.7 Million USD | 1.22% |
| 2020 Q2 | 485.05 Million USD | -1.35% |
| 2020 Q1 | 491.68 Million USD | -1.8% |
| 2020 FY | 2.07 Billion USD | 5.93% |
| 2019 Q1 | 467.34 Million USD | 7.59% |
| 2019 FY | 1.95 Billion USD | 17.63% |
| 2019 Q2 | 492.98 Million USD | 5.49% |
| 2019 Q3 | 494.63 Million USD | 0.33% |
| 2019 Q4 | 500.67 Million USD | 1.22% |
| 2018 Q1 | 399.26 Million USD | -1.23% |
| 2018 Q2 | 411.6 Million USD | 3.09% |
| 2018 Q4 | 434.37 Million USD | 4.08% |
| 2018 Q3 | 417.33 Million USD | 1.39% |
| 2018 FY | 1.66 Billion USD | 8.4% |
| 2017 Q4 | 404.23 Million USD | 6.33% |
| 2017 FY | 1.53 Billion USD | 6.69% |
| 2017 Q1 | 370.45 Million USD | 1.14% |
| 2017 Q2 | 378.82 Million USD | 2.26% |
| 2017 Q3 | 380.16 Million USD | 0.35% |
| 2016 Q2 | 360.74 Million USD | 3.42% |
| 2016 Q4 | 366.29 Million USD | 1.3% |
| 2016 Q1 | 348.81 Million USD | 3.09% |
| 2016 Q3 | 361.59 Million USD | 0.24% |
| 2016 FY | 1.43 Billion USD | 12.25% |
| 2015 Q3 | 326.45 Million USD | 3.91% |
| 2015 Q4 | 338.36 Million USD | 3.65% |
| 2015 Q2 | 314.15 Million USD | 4.17% |
| 2015 Q1 | 301.57 Million USD | 0.35% |
| 2015 FY | 1.28 Billion USD | 6.31% |
| 2014 Q4 | 300.52 Million USD | 0.08% |
| 2014 Q2 | 305 Million USD | 2.1% |
| 2014 FY | 1.2 Billion USD | -3.59% |
| 2014 Q3 | 300.28 Million USD | -1.55% |
| 2014 Q1 | 298.73 Million USD | -1.14% |
| 2013 Q2 | 313.14 Million USD | -7.67% |
| 2013 FY | 1.24 Billion USD | -16.03% |
| 2013 Q4 | 302.17 Million USD | 0.18% |
| 2013 Q3 | 301.63 Million USD | -3.68% |
| 2013 Q1 | 339.17 Million USD | -6.55% |
| 2012 FY | 1.48 Billion USD | 1.19% |
| 2012 Q1 | 370.83 Million USD | 3.74% |
| 2012 Q2 | 378.49 Million USD | 2.07% |
| 2012 Q3 | 375.62 Million USD | -0.76% |
| 2012 Q4 | 362.94 Million USD | -3.37% |
| 2011 Q3 | 374.86 Million USD | 0.3% |
| 2011 FY | 1.47 Billion USD | -10.03% |
| 2011 Q1 | 364.3 Million USD | -7.61% |
| 2011 Q4 | 357.47 Million USD | -4.64% |
| 2011 Q2 | 373.72 Million USD | 2.59% |
| 2010 Q1 | 412.96 Million USD | 1.85% |
| 2010 Q2 | 422.34 Million USD | 2.27% |
| 2010 Q3 | 404.68 Million USD | -4.18% |
| 2010 Q4 | 394.32 Million USD | -2.56% |
| 2010 FY | 1.63 Billion USD | 7.99% |
| 2009 FY | 1.51 Billion USD | 27.46% |
| 2009 Q4 | 405.47 Million USD | 4.43% |
| 2009 Q3 | 388.25 Million USD | 2.74% |
| 2009 Q2 | 377.89 Million USD | 10.55% |
| 2009 Q1 | 341.83 Million USD | 0.51% |
| 2008 Q3 | 321.56 Million USD | 2.84% |
| 2008 Q4 | 340.09 Million USD | 5.76% |
| 2008 FY | 1.18 Billion USD | 70.13% |
| 2008 Q2 | 312.67 Million USD | 46.73% |
| 2008 Q1 | 213.08 Million USD | 9.85% |
| 2007 Q1 | 153.58 Million USD | 6.65% |
| 2007 FY | 697.93 Million USD | 28.97% |
| 2007 Q4 | 193.98 Million USD | 7.23% |
| 2007 Q3 | 180.91 Million USD | 6.76% |
| 2007 Q2 | 169.45 Million USD | 10.34% |
| 2006 Q4 | 144.01 Million USD | 5.09% |
| 2006 Q3 | 137.04 Million USD | 3.11% |
| 2006 Q2 | 132.91 Million USD | 4.5% |
| 2006 Q1 | 127.18 Million USD | 6.98% |
| 2006 FY | 541.14 Million USD | 41.83% |
| 2005 Q2 | 80.06 Million USD | 13.66% |
| 2005 FY | 381.55 Million USD | 68.02% |
| 2005 Q4 | 118.89 Million USD | 6.0% |
| 2005 Q3 | 112.16 Million USD | 40.1% |
| 2005 Q1 | 70.43 Million USD | 9.44% |
| 2004 Q2 | 56.89 Million USD | 20.19% |
| 2004 Q4 | 64.36 Million USD | 10.03% |
| 2004 Q3 | 58.49 Million USD | 2.81% |
| 2004 Q1 | 47.33 Million USD | 12.45% |
| 2004 FY | 227.08 Million USD | 59.39% |
| 2003 Q3 | 37.04 Million USD | 15.08% |
| 2003 Q2 | 32.19 Million USD | 3.41% |
| 2003 FY | 142.47 Million USD | 10.08% |
| 2003 Q1 | 31.13 Million USD | -1.65% |
| 2003 Q4 | 42.09 Million USD | 13.63% |
| 2002 Q3 | 33.06 Million USD | 0.65% |
| 2002 Q2 | 32.85 Million USD | 3.15% |
| 2002 FY | 129.42 Million USD | 17.47% |
| 2002 Q4 | 31.65 Million USD | -4.27% |
| 2002 Q1 | 31.85 Million USD | 2.31% |
| 2001 Q3 | 29.67 Million USD | 9.1% |
| 2001 Q4 | 31.13 Million USD | 4.92% |
| 2001 FY | 110.17 Million USD | 21.4% |
| 2001 Q1 | 26.17 Million USD | 19.09% |
| 2001 Q2 | 27.19 Million USD | 3.92% |
| 2000 FY | 90.75 Million USD | -6.83% |
| 2000 Q4 | 21.97 Million USD | -0.52% |
| 2000 Q1 | 23.41 Million USD | -0.35% |
| 2000 Q3 | 22.09 Million USD | -5.07% |
| 2000 Q2 | 23.27 Million USD | -0.63% |
| 1999 Q3 | 24.2 Million USD | -1.63% |
| 1999 FY | 97.41 Million USD | 155.77% |
| 1999 Q4 | 23.5 Million USD | -2.89% |
| 1999 Q2 | 24.6 Million USD | -1.82% |
| 1999 Q1 | 25.05 Million USD | 54.81% |
| 1998 Q4 | 16.18 Million USD | 161.06% |
| 1998 Q1 | 12.7 Million USD | -3.02% |
| 1998 FY | 38.08 Million USD | -30.11% |
| 1998 Q2 | 11.8 Million USD | -7.09% |
| 1998 Q3 | 6.2 Million USD | -47.46% |
| 1997 Q3 | 14.1 Million USD | 1.44% |
| 1997 FY | 54.49 Million USD | 18.31% |
| 1997 Q4 | 13.09 Million USD | -7.12% |
| 1997 Q1 | 13.4 Million USD | 7.54% |
| 1997 Q2 | 13.9 Million USD | 3.73% |
| 1996 Q2 | 11.8 Million USD | 16.83% |
| 1996 Q3 | 11.8 Million USD | 0.0% |
| 1996 Q4 | 12.46 Million USD | 5.6% |
| 1996 FY | 46.06 Million USD | 22.5% |
| 1996 Q1 | 10.1 Million USD | 2.02% |
| 1995 Q2 | 9.3 Million USD | 19.23% |
| 1995 Q1 | 7.8 Million USD | 20.0% |
| 1995 FY | 37.6 Million USD | 53.47% |
| 1995 Q4 | 9.9 Million USD | 1.02% |
| 1995 Q3 | 9.8 Million USD | 5.38% |
| 1994 FY | 24.5 Million USD | 75.0% |
| 1994 Q4 | 6.5 Million USD | 0.0% |
| 1994 Q1 | 5.6 Million USD | 143.48% |
| 1994 Q2 | 5.9 Million USD | 5.36% |
| 1994 Q3 | 6.5 Million USD | 10.17% |
| 1993 FY | 14 Million USD | 0.0% |
| 1993 Q3 | 2.3 Million USD | -51.06% |
| 1993 Q2 | 4.7 Million USD | 2.17% |
| 1993 Q1 | 4.6 Million USD | 0.0% |
| 1993 Q4 | 2.3 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 23.64% |
| Addus HomeCare Corporation | 1.05 Billion USD | -111.248% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -1041.495% |
| American Oncology Network, Inc. | 1.27 Billion USD | -74.829% |
| Astrana Health, Inc. | 1.38 Billion USD | -61.278% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | -18.002% |
| IMAC Holdings, Inc. | 5.19 Million USD | -42932.172% |
| biote Corp. | 185.36 Million USD | -1106.507% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -7035.03% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | -10.727% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -258.229% |
| The Ensign Group, Inc. | 3.72 Billion USD | 40.033% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | -33.804% |
| InnovAge Holding Corp. | 763.85 Million USD | -192.776% |
| Assure Holdings Corp. | 255 Thousand USD | -876912.549% |
| The Joint Corp. | 117.69 Million USD | -1800.128% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -111.846% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -21489.789% |
| ModivCare Inc. | 2.75 Billion USD | 18.712% |
| NewGenIvf Group Limited | 5.13 Million USD | -43441.966% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -17688.567% |
| Option Care Health, Inc. | 4.3 Billion USD | 48.019% |
| P3 Health Partners Inc. | 1.26 Billion USD | -76.597% |
| P3 Health Partners Inc. | 1.26 Billion USD | -76.597% |
| The Pennant Group, Inc. | 544.89 Million USD | -310.427% |
| Surgery Partners, Inc. | 2.74 Billion USD | 18.478% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -40449.839% |
| Talkspace, Inc. | 150.04 Million USD | -1390.474% |
| Talkspace, Inc. | 150.04 Million USD | -1390.474% |
| The Oncology Institute, Inc. | 324.23 Million USD | -589.733% |
| The Oncology Institute, Inc. | 324.23 Million USD | -589.733% |